Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

Completed

• Conditions: COVID-19

• Registration Number: NCT04561193
• Lead Sponsor: Methodist Health System

Brief Summary

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals

Detailed Description

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals (Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas) between February 1 and April 30, 2020. All study center utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from.

Study Timeline

• Study Start: 2020-05-30
• Study First Submitted: 2020-09-22
• Study First Submitted QC: 2020-09-22
• Study First Posted: 2020-09-23
• Status Verified: 2022-05
• Primary Completion: 2022-05-23
• Study Completion: 2022-05-23
• Last Update Submitted: 2022-05-24
• Last Update Posted: 2022-05-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 417

Inclusion Criteria

• Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020
• >18 years old
• Positive SARS-CoV-2 (COVID-19) PCR test

Exclusion Criteria

• Outpatient or emergency department visit
• Not admitted to an inpatient or observation status for >24 hours

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of subsequent and co-infections	Feb 2020 - April 2020	Prevalence of subsequent and co-infections

Secondary Outcome Measures

Name	Time	Method
Hospital length of stay (LOS)	Feb 2020 - April 2020	Hospital length of stay (LOS)
In-hospital mortality	Feb 2020 - April 2020	In-hospital mortality

Trial Locations

Locations (1)

Methodist Dallas Medical Center; 🇺🇸 Dallas, Texas, United States